1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

HaplnScience, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2018

Location

Seongnam South Korea

Primary Industry

Pharmaceuticals

About

Based in Gyeonggi-do, South Korea, and founded in 2018, HaplnScience, Inc. is a pharmaceutical company that researches and develops new drugs for aging-related diseases utilizing hyaluronan and proteoglycan link protein 1 (HAPLN1). The company's clinical development pipeline includes treatments for osteoarthritis, skin aging, hair loss, and desmosis.
Current Investors
Bluepoint Partners, Korea Tech Incubator for Startup, DSC Investment

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.haplnscience.com
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo